We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
V3V.F

Price
3.84
Stock movement up
+- (%)
Company name
VITA 34 AG
Exchange
(F
,
Currency
EUR
)
Sector
Healthcare >
Medical Care Facilities
Market cap
66.94M
Ent value
188.08M
Price/Sales
0.85
Price/Book
3.03
Div yield
-
Div growth
-
Growth years
-
FCF payout
0.03%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-9.86%
3 year return
-32.25%
5 year return
-19.70%
10 year return
-4.63%
Last updated: 2025-04-05

DIVIDENDS

V3V.F does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF6.33
Price to FCF9.40
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales0.85
Price to Book3.03
EV to Sales2.39

FINANCIALS

Per share

Per share data
Current share count17.43M
EPS (TTM)-0.01
FCF per share (TTM)0.41

Income statement

Income statement data
Revenue (TTM)78.82M
Gross profit (TTM)29.91M
Operating income (TTM)-1.11M
Net income (TTM)-127.00K
EPS (TTM)-0.01
EPS (1y forward)-0.02

Margins

Margins data
Gross margin (TTM)37.95%
Operating margin (TTM)-1.41%
Profit margin (TTM)-0.16%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash14.44M
Net receivables13.05M
Total current assets37.91M
Goodwill39.25M
Intangible assets16.18M
Property, plant and equipment37.03M
Total assets157.65M
Accounts payable7.20M
Short/Current long term debt0.00
Total current liabilities53.10M
Total liabilities135.58M
Shareholder's equity22.07M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)10.57M
Capital expenditures (TTM)3.45M
Free cash flow (TTM)7.12M
Dividends paid (TTM)2.00K

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-0.58%
Return on Assets-0.08%
Return on Invested Capital-0.51%
Cash Return on Invested Capital28.58%

STOCK INFORMATION

Stock chart

Stock price data
Open3.84
Daily high4.00
Daily low3.84
Daily Volume0K
All-time high18.00
1y analyst estimate6.30
Beta0.62
EPS (TTM)-0.01
Dividend per share-
Ex-div date5 Jun 2019
Next earnings date29 May 2025

Downside potential

Downside potential data
V3V.FS&P500
Current price drop from All-time high-78.67%-12.44%
Highest price drop-88.28%-56.47%
Date of highest drop16 Mar 20099 Mar 2009
Avg drop from high-57.82%-11.07%
Avg time to new high176 days12 days
Max time to new high4424 days1805 days
COMPANY DETAILS
V3V.F (VITA 34 AG) company logo
Marketcap
66.94M
Marketcap category
Small-cap
Description
VITA 34 AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the company provides biobanking services, such as freezing sperm and storage of adipose tissue and the isolation of cells from the stored materials. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.
Employees
745
Website
https://www.vita34.de
Investor relations
-
SEC filings
V3V.F SEC filings
CEO
Country
Germany
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
We Think VITA 34's (ETR:V3V) Robust Earnings Are Conservative
Even though VITA 34 AG's ( ETR:V3V ) recent earnings release was robust, the market didn't seem to notice. Our analysis...
December 1, 2024
VITA 34 (ETR:V3V) investors are sitting on a loss of 76% if they invested three years ago
Every investor on earth makes bad calls sometimes. But really big losses can really drag down an overall portfolio. So...
November 21, 2024
VITA 34 Second Quarter 2024 Earnings: €0.10 loss per share (vs €0.07 loss in 2Q 2023)
VITA 34 ( ETR:V3V ) Second Quarter 2024 Results Key Financial Results Revenue: €19.5m (up 6.0% from 2Q 2023). Net loss...
September 1, 2024
The past three years for VITA 34 (ETR:V3V) investors has not been profitable
Every investor on earth makes bad calls sometimes. But really bad investments should be rare. So spare a thought for...
June 5, 2024
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved